Skip to main content

Table 1 The clinical characteristics of 20 glioma patients

From: ARL2 overexpression inhibits glioma proliferation and tumorigenicity via down-regulating AXL

Characteristics Number of patients (n = 20)
Age(years)
 <50 8 (40%)
 ≥ 50 12 (60%)
Gender
 Male 12 (60%)
 Female 8 (40%)
WHO grade
 II 3 (15%)
 III 9 (45%)
 IV 8 (40%)
Tumor size
 <4 cm 11 (55%)
 ≥ 4 cm 9 (45%)
Primary/Recurrent
 Primary 17 (85%)
 Recurrent 3 (15%)
IDH1 state
 IDH1(−) 11 (55%)
 IDH1(+) 9 (45%)